Medicines and Healthcare Products Regulatory Agency

The complainant has requested information relating to Non-Disclosure Agreements (NDAs) entered into by the Medicines & Healthcare Products Regulatory Agency (MHRA). The Commissioner’s decision is that MHRA correctly cited section 12(2) in response to the request. However, the Commissioner considers that MHRA breached section 16 FOIA (advice and assistance) as it did not offer to consider a refined request. As MHRA has now contacted the complainant to advise of this, no further steps are required as a result of this decision notice.